Kraig Biocraft Laboratories, Inc. (KBLB)
OTCMKTS · Delayed Price · Currency is USD
0.1140
-0.0160 (-12.31%)
Mar 4, 2026, 3:53 PM EST

KBLB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
12596403278107
Market Cap Growth
25.56%140.82%25.13%-58.95%-27.40%-34.48%
Enterprise Value
131102443584115
Last Close Price
0.110.090.040.030.080.13
PB Ratio
-15.75-11.82-7.01-9.07-14.70-16.31
Debt / Equity Ratio
-0.22-0.21-0.31-0.50-0.46-0.36
Net Debt / Equity Ratio
-0.02-0.130.140.62-0.01-0.24
Net Debt / EBITDA Ratio
-0.05-0.340.311.05-0.02-0.35
Net Debt / FCF Ratio
-0.10-0.560.641.16-0.03-1.25
Quick Ratio
0.150.070.290.490.290.11
Current Ratio
0.160.080.290.490.290.11
Return on Assets (ROA)
-96.06%-81.11%-41.88%-34.92%-80.23%-279.45%
Return on Capital Employed (ROCE)
43.00%37.90%46.30%60.60%53.70%73.40%
Earnings Yield
-2.94%-3.53%-7.58%-12.02%-10.33%-4.64%
FCF Yield
-1.48%-1.91%-3.13%-5.92%-2.44%-1.17%
Buyback Yield / Dilution
-1.14%-0.51%-6.04%-11.02%-3.41%-1.56%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.